Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.21 with a market capitalization of $41.6B.
Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026. Insmed Incorporated operates in the Healthcare sector. The…

Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.21 with a market capitalization of $41.6B.
Current market data
NASDAQ · INSM
$112.58
Up: +$0.99 · +0.89%
Live quote updated
Keep reading